LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 25th Prioritisation – 4th quarter 2015

Grössmann, N. and Wild, C. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 25th Prioritisation – 4th quarter 2015. HSO: 25th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
335Kb
Abstract

For the 25th prioritisation (December 2015), 11 drugs were filtered out of 199 identified and were sent to prioritisation. Of these, 3 drugs were ranked as 'highly relevant' by the expert panel, 8 as 'relevant' and none as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
Language:English
Series Name:HSO: 25th Prioritisation
Deposited on:27 Jan 2016 14:55
Last Modified:02 Feb 2016 15:07

Repository Staff Only: item control page